Top Markets
Coin of the day
Gelesis Holdings, Inc. Gelesis Holdings, Inc.

Gelesis Holdings, Inc.

GLS
Rang in aandelen #40695
Gelesis Holdings Inc. is a biopharmaceutical company actively marketing... Gelesis Holdings Inc. is a biopharmaceutical company actively marketing products, dedicated to creating biomimetic solutions that target the underlying causes of obesity and chronic gastrointestinal conditions. Among its key offerings is PLENITY, an oral therapeutic designed for weight management that is non-stimulant and does not enter the bloodstream. The company also provides an additional product for individuals who are overweight or obese, and its robust pipeline features potential treatments for non-alcoholic fatty liver disease/non-alcoholic steatohepatitis, type 2 diabetes, and GS500 for Functional Constipation. Established in 2006, Gelesis Holdings Inc. operates from its headquarters in Boston, Massachusetts.
Aandeelprijs
$0.0121
Laatst gesynchroniseerd: 2023-05-23
Marktkapitalisatie
$97.54K
Verandering (1 dag)
-24.38%
Verandering (1 jaar)
0.00%
Land
US
Handel Gelesis Holdings, Inc. (GLS)

Categorie

Dividendrendementgeschiedenis voor Gelesis Holdings, Inc. (GLS)
Het dividendrendement (TTM) van Gelesis Holdings, Inc. (aandelsymbool: GLS) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van Gelesis Holdings, Inc. (GLS) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten